Here, we have demonstrated that the engraftment of the CD34+ cells does not affect the formation of the bone cortical shell, which also opens the door to testing a number of drugs addressing not only bone lesions in bone resorptive states, such as MM, but also potentially bone metastasis in other tumour types. The gene discussed is CD34; the disease is Miyoshi myopathy.